Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097-6110

Curr Oncol. 2024 Nov 15;31(11):7177-7179. doi: 10.3390/curroncol31110529.

¹ Breast Tumors Unit, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.
² Gastrointestinal Oncology Unit, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.
³ Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnológico de Monterrey, San Pedro Garza García 66278, Mexico.
⁴ Grupo Opción Oncología, Monterrey 64060, Mexico.
⁵ School of Medicine, Universidad Panamericana, Mexico City 03920, Mexico.
⁶ Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.

Abstract

In the original publication [...].